Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
The Regulation of Biosimilars: How are Biosimilars Approved, Named,Patents Protected?
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Presentation
- By: SCHNEIDER, Philip (Alliance for Safe Biologic Medicines) The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019